Contents

Current Cancer Drug Targets, Volume 7 - Number 3

Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?

, 7(3): 209 - 215

G. Garcea, M. M. Manson, C. P. Neal, C. J. Pattenden, C. D. Sutton, A. R. Dennison and D. P. Berry


DOI: 10.2174/156800907780618266




Metastasis-Associated Protein S100A4: Spotlight on its Role in Cell Migration

, 7(3): 217 - 228

S. Tarabykina, T. R. L. Griffiths, E. Tulchinsky, J. K. Mellon, I. B. Bronstein and M. Kriajevska


DOI: 10.2174/156800907780618329




Cancer Vaccines for Hormone/Growth Factor Immune Deprivation:A Feasible Approach for Cancer Treatment

, 7(3): 229 - 241

G. Gonzalez and A. Lage


DOI: 10.2174/156800907780618310




Non-Homologous DNA End Joining in Anticancer Therapy

, 7(3): 243 - 250

Elzbieta Pastwa and Mariusz Malinowski


DOI: 10.2174/156800907780618284




The Kinase Inhibitor Imatinib - An Immunosuppressive Drug?

, 7(3): 251 - 258

D. Wolf, H. Tilg, H. Rumpold, G. Gastl and A. M. Wolf


DOI: 10.2174/156800907780618293




MUC1 is a Promising Therapeutic Target for Prostate Cancer Therapy

, 7(3): 259 - 271

Y. Li and P. J. Cozzi


DOI: 10.2174/156800907780618338




Current Status and Future of Target-Based Therapeutics

, 7(3): 273 - 284

Ryoko Suzuki, Parijatha Rao and Shiro Sasaguri


DOI: 10.2174/156800907780618275




Conditionally Replicating Adenoviruses for Cancer Treatment

, 7(3): 285 - 301

Youssef Jounaidi, Joshua C. Doloff and David J. Waxman


DOI: 10.2174/156800907780618301




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science